Couture P, Lamarche B: Ezetimibe localizes and appears to act at the brush border of the small intestine and inhibits the absorption of cholesterol. Please provide a valid email address. The two contraindications to taking ezetimibe are a previous allergic reaction including rash, angioedemaand anaphylaxisand severe liver disease, especially when taken with a statin. Colesevelam can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.
The risk or severity of adverse effects can be increased when Cabergoline is combined with Ezetimibe.
Infrequent adverse effects 0. References van Heek, M.
Available for Immediate Shipment. S4 Prescription only CA: Its unique specificity for 3,4-catechol estrogens and estriol su Ezetimibe phenoxy glucuronide Ezetimibe phenoxy glucuronide Worldwide Suppliers of Ezetimibe phenoxy glucuronide https: After oral administration, ezetimibe is absorbed and extensively conjugated to a pharmacologically active phenolic glucuronide ezetimibe-glucuronide. Epub Oct Plays a role in lipoprotein assembly and dietary cholesterol absorption. Plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases.
The email address or password you have entered is incorrect. Lipid modifying agents C General Function Organic anion transmembrane transporter activity Specific Function Mediates hepatobiliary excretion of numerous organic anions. While ezetimibe reduces LDL cholesterol, it has not been shown to affect outcomes such as risk of death or major cardiovascular event like heart attack or stroke. Retrieved 15 July The absolute bioavailability cannot be determined, since ezetimibe is insoluble in aqueous media suitable for injection.
General Function Retinoic acid binding Specific Function UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Ezetimibe inhibits the absorption of cholesterol from the small intestine and decreases the amount of cholesterol normally available to liver cells, leading them to absorb more from circulation and thus lowering levels of circulating cholesterol. Ezetimibe is primarily metabolized in the small intestine and liver via glucuronide conjugation a phase II reaction with subsequent biliary and renal excretion.
Ezetimibe has a mechanism of action that differs from those of other classes of cholesterol-reducing compounds HMG-CoA reductase inhibitors, bile acid sequestrants, fibric acid derivatives, and plant stanols.